...
首页> 外文期刊>Life sciences >MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.
【24h】

MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.

机译:MAPK(ERK2)激酶-NSAIDs抑制胃癌细胞增殖和生长的关键靶标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Limited clinical and experimental studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may inhibit gastric cancer growth. However, the mechanisms involved are not completely understood and cannot be explained by COX-2 inhibition alone. MAPK signaling pathway is essential for cell proliferation, but the effect of NSAIDs on MAPK activity and phosphorylation in gastric cancer has never been studied. Since increased and unregulated cell proliferation and reduced cell apoptosis are important features of cancer growth, we studied whether NS-398, a selective COX-2 inhibitor and/ or indomethacin (IND), a non-selective NSAID: 1) inhibit gastric cancer cell proliferation, 2) whether this inhibition is mediated via MAPK (ERK2), and 3) whether NSAIDs enhance apoptosis in gastric cancer cells. Human gastric epithelial cells (MKN28) derived from gastric tubular adenocarcinoma were cultured and treated with either vehicle, IND (0.25-0.5mM) or NS-398 (50-100 microM) for 6, 16, 24 and 48h. Studies: 1) Cellular proliferation was determined by 3H-thymidine uptake. 2) MAPK activity was measured by incorporation of radiolabeled phosphate into myelin basic protein. 3) Apoptosis was evaluated using TUNEL assay. IND and NS-398 significantly inhibited the proliferation of MKN28 cells at 24h by 3.5 - 5 fold (p<0.002) and at 48h by 2.5 - 10 fold (p<0.02). Both NSAIDs also significantly inhibited ERK2 activity: IND >53% inhibition, NS-398, 100 microM >72% inhibition; all p<0.05. Both IND and NS-398 significantly increased apoptotic index. In conclusion, IND and NS-398 significantly inhibit proliferation and growth of human gastric cancer cell line MKN28. This effect is mediated by NSAID-induced inhibition of MAPK (ERK2) kinase signaling pathway, essential for cell proliferation. NSAIDs also increase apoptosis in MKN28 cells. In addition to inhibiting cyclooxygenase, NSAIDs inhibit phosphorylating enzymes--kinases essential for signaling cell proliferation.
机译:有限的临床和实验研究表明,非甾体类抗炎药(NSAIDs)可能抑制胃癌的生长。但是,所涉及的机制尚未完全理解,不能仅通过抑制COX-2来解释。 MAPK信号通路对于细胞增殖至关重要,但是从未研究过NSAID对胃癌MAPK活性和磷酸化的影响。由于增加和不受控制的细胞增殖和减少的细胞凋亡是癌症生长的重要特征,因此我们研究了选择性COX-2抑制剂NS-398和/或非选择性NSAID吲哚美辛(IND)是否抑制胃癌细胞2)这种抑制作用是否通过MAPK(ERK2)介导,以及3)NSAID是否增强胃癌细胞的凋亡。培养源自胃小管腺癌的人胃上皮细胞(MKN28),并用媒介物IND(0.25-0.5mM)或NS-398(50-100 microM)处理6、16、24和48h。研究:1)细胞增殖通过3H-胸苷的摄取来确定。 2)通过将放射性标记的磷酸盐掺入髓鞘碱性蛋白中来测量MAPK活性。 3)使用TUNEL测定法评价细胞凋亡。 IND和NS-398在24小时显着抑制MKN28细胞的增殖3.5-5倍(p <0.002),在48h抑制2.5-10倍(p <0.02)。两种NSAID均也显着抑制ERK2活性:IND> 53%抑制,NS-398,100 microM> 72%抑制;全部p <0.05。 IND和NS-398均显着增加凋亡指数。总之,IND和NS-398显着抑制人胃癌细胞系MKN28的增殖和生长。这种作用是由NSAID诱导的对MAPK(ERK2)激酶信号通路的抑制所介导的,该通路对于细胞增殖至关重要。 NSAID也增加MKN28细胞的凋亡。除了抑制环氧合酶外,NSAID还抑制磷酸化酶(一种信号传导细胞增殖所必需的激酶)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号